Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon

Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2009-03, Vol.159 (2), p.618
Hauptverfasser: Rajagopal, S, Fang, H, Oronce, C I A, Jhaveri, S, Taneja, S, Dehlin, E M, Snyder, S L, Sando, J J, Kamatchi, G L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 618
container_title Neuroscience
container_volume 159
creator Rajagopal, S
Fang, H
Oronce, C I A
Jhaveri, S
Taneja, S
Dehlin, E M
Snyder, S L
Sando, J J
Kamatchi, G L
description Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocytes can be blocked by inhibitors of PKC betaII or PKC epsilon isozymes, as shown previously for Ca(v)2.3 currents, and that microinjection of PKC betaII or PKC epsilon isozymes in the oocytes expressing the WT Ca(v)2.2 channels increases the basal barium current (I(Ba)). The I-V plot shows a large increase in current amplitude with PKC betaII and PKC epsilon isozymes with only a small shift in the peak I(Ba) in the hyperpolarizing direction. The potentiation of Ca(v)2.2 currents by microinjection of PKC betaII and PKC epsilon isozymes was not altered by the inhibition of G proteins with GDPbetaS. The combination of isozyme specific inhibitors with previously generated Ser/Thr to Ala mutants of alpha(1) 2.2 subunit revealed that PKC betaII or PKC epsilon isozymes (but not PKC alpha or delta) can provide full enhancement through the stimulatory site (Thr-422) in the I-II linker but that PKC epsilon is better at decreasing channel activity through the inhibitory site Ser-425. The enhancing effect of PKC betaII or epsilon at Thr-422 is dominant over the inhibitory effect at Ser-425. Injected PKC betaII also enhances Ca(v)2.2 current when any of the potential stimulatory sites (Ser-1757, Ser-2108 and Ser-2132) are available in the C-terminus. PKC epsilon provides lesser enhancement with C-terminal sites and only with Ser-2108 and Ser-2132. Sites Ser-1757 and Ser-2132, but not Ser-2108, are dominant over the inhibitory site Ser-425. Collectively, these results reveal a hierarchy of regulatory sites in Ca(v)2.2 channels. Site-specific regulation by different PKC isozymes may allow graded levels of channel activation and susceptibility or resistance to subsequent stimulatory events.
doi_str_mv 10.1016/j.neuroscience.2008.12.047
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_19167461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19167461</sourcerecordid><originalsourceid>FETCH-LOGICAL-p541-58718902cb631400af446f88073de2907065a2e41c2079a81416ae083d61368b3</originalsourceid><addsrcrecordid>eNo1j7FOwzAURT2AaCn8ArKYYEh4z3YcZ6wiCpEqMVCxocpxXsAldaI4HcrXUwm4yxmOdKTL2C1CioD6YZcGOox9dJ6Co1QAmBRFCio_Y3OQoBOVCTFjlzHu4LRMyQs2wwJ1rjTO2furnyiJAznfesdH-jh0dvJ94H3Ly-Xd271IBXefNgTqIq-PfBj7iXzgXz7YSLzkPvbfxz2dJE22qrgNDach-q4PV-y8tV2k6z8u2Gb1uCmfk_XLU1Uu18mQKUwyk6MpQLhaS1QAtlVKt8ZALhsSBeSgMytIoROQF9agQm0JjGw0Sm1quWA3v9nhUO-p2Q6j39vxuP2_KX8A6ExUtg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rajagopal, S ; Fang, H ; Oronce, C I A ; Jhaveri, S ; Taneja, S ; Dehlin, E M ; Snyder, S L ; Sando, J J ; Kamatchi, G L</creator><creatorcontrib>Rajagopal, S ; Fang, H ; Oronce, C I A ; Jhaveri, S ; Taneja, S ; Dehlin, E M ; Snyder, S L ; Sando, J J ; Kamatchi, G L</creatorcontrib><description>Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocytes can be blocked by inhibitors of PKC betaII or PKC epsilon isozymes, as shown previously for Ca(v)2.3 currents, and that microinjection of PKC betaII or PKC epsilon isozymes in the oocytes expressing the WT Ca(v)2.2 channels increases the basal barium current (I(Ba)). The I-V plot shows a large increase in current amplitude with PKC betaII and PKC epsilon isozymes with only a small shift in the peak I(Ba) in the hyperpolarizing direction. The potentiation of Ca(v)2.2 currents by microinjection of PKC betaII and PKC epsilon isozymes was not altered by the inhibition of G proteins with GDPbetaS. The combination of isozyme specific inhibitors with previously generated Ser/Thr to Ala mutants of alpha(1) 2.2 subunit revealed that PKC betaII or PKC epsilon isozymes (but not PKC alpha or delta) can provide full enhancement through the stimulatory site (Thr-422) in the I-II linker but that PKC epsilon is better at decreasing channel activity through the inhibitory site Ser-425. The enhancing effect of PKC betaII or epsilon at Thr-422 is dominant over the inhibitory effect at Ser-425. Injected PKC betaII also enhances Ca(v)2.2 current when any of the potential stimulatory sites (Ser-1757, Ser-2108 and Ser-2132) are available in the C-terminus. PKC epsilon provides lesser enhancement with C-terminal sites and only with Ser-2108 and Ser-2132. Sites Ser-1757 and Ser-2132, but not Ser-2108, are dominant over the inhibitory site Ser-425. Collectively, these results reveal a hierarchy of regulatory sites in Ca(v)2.2 channels. Site-specific regulation by different PKC isozymes may allow graded levels of channel activation and susceptibility or resistance to subsequent stimulatory events.</description><identifier>ISSN: 0306-4522</identifier><identifier>DOI: 10.1016/j.neuroscience.2008.12.047</identifier><identifier>PMID: 19167461</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Aspartic Acid - genetics ; Calcium Channels, N-Type - drug effects ; Calcium Channels, N-Type - genetics ; Calcium Channels, N-Type - metabolism ; Dose-Response Relationship, Drug ; Enzyme Activation - drug effects ; Enzyme Activation - genetics ; Enzyme Inhibitors - pharmacology ; Female ; Gene Expression Regulation - drug effects ; Gene Expression Regulation - physiology ; Guanosine Diphosphate - analogs &amp; derivatives ; Guanosine Diphosphate - pharmacology ; Membrane Potentials - drug effects ; Membrane Potentials - genetics ; Microinjections - methods ; Mutation - genetics ; Oocytes ; Patch-Clamp Techniques ; Phorbol Esters - pharmacology ; Phosphorylation - genetics ; Protein Kinase C - genetics ; Protein Kinase C - metabolism ; Protein Kinase C - pharmacology ; Protein Kinase C beta ; Protein Kinase C-epsilon - genetics ; Protein Kinase C-epsilon - metabolism ; Protein Kinase C-epsilon - pharmacology ; Protein Structure, Tertiary - physiology ; RNA, Small Interfering - pharmacology ; Serine - genetics ; Serine - metabolism ; Thionucleotides - pharmacology ; Threonine - genetics ; Xenopus laevis ; Xenopus Proteins - drug effects ; Xenopus Proteins - genetics ; Xenopus Proteins - metabolism</subject><ispartof>Neuroscience, 2009-03, Vol.159 (2), p.618</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19167461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rajagopal, S</creatorcontrib><creatorcontrib>Fang, H</creatorcontrib><creatorcontrib>Oronce, C I A</creatorcontrib><creatorcontrib>Jhaveri, S</creatorcontrib><creatorcontrib>Taneja, S</creatorcontrib><creatorcontrib>Dehlin, E M</creatorcontrib><creatorcontrib>Snyder, S L</creatorcontrib><creatorcontrib>Sando, J J</creatorcontrib><creatorcontrib>Kamatchi, G L</creatorcontrib><title>Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocytes can be blocked by inhibitors of PKC betaII or PKC epsilon isozymes, as shown previously for Ca(v)2.3 currents, and that microinjection of PKC betaII or PKC epsilon isozymes in the oocytes expressing the WT Ca(v)2.2 channels increases the basal barium current (I(Ba)). The I-V plot shows a large increase in current amplitude with PKC betaII and PKC epsilon isozymes with only a small shift in the peak I(Ba) in the hyperpolarizing direction. The potentiation of Ca(v)2.2 currents by microinjection of PKC betaII and PKC epsilon isozymes was not altered by the inhibition of G proteins with GDPbetaS. The combination of isozyme specific inhibitors with previously generated Ser/Thr to Ala mutants of alpha(1) 2.2 subunit revealed that PKC betaII or PKC epsilon isozymes (but not PKC alpha or delta) can provide full enhancement through the stimulatory site (Thr-422) in the I-II linker but that PKC epsilon is better at decreasing channel activity through the inhibitory site Ser-425. The enhancing effect of PKC betaII or epsilon at Thr-422 is dominant over the inhibitory effect at Ser-425. Injected PKC betaII also enhances Ca(v)2.2 current when any of the potential stimulatory sites (Ser-1757, Ser-2108 and Ser-2132) are available in the C-terminus. PKC epsilon provides lesser enhancement with C-terminal sites and only with Ser-2108 and Ser-2132. Sites Ser-1757 and Ser-2132, but not Ser-2108, are dominant over the inhibitory site Ser-425. Collectively, these results reveal a hierarchy of regulatory sites in Ca(v)2.2 channels. Site-specific regulation by different PKC isozymes may allow graded levels of channel activation and susceptibility or resistance to subsequent stimulatory events.</description><subject>Animals</subject><subject>Aspartic Acid - genetics</subject><subject>Calcium Channels, N-Type - drug effects</subject><subject>Calcium Channels, N-Type - genetics</subject><subject>Calcium Channels, N-Type - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Activation - genetics</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene Expression Regulation - physiology</subject><subject>Guanosine Diphosphate - analogs &amp; derivatives</subject><subject>Guanosine Diphosphate - pharmacology</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - genetics</subject><subject>Microinjections - methods</subject><subject>Mutation - genetics</subject><subject>Oocytes</subject><subject>Patch-Clamp Techniques</subject><subject>Phorbol Esters - pharmacology</subject><subject>Phosphorylation - genetics</subject><subject>Protein Kinase C - genetics</subject><subject>Protein Kinase C - metabolism</subject><subject>Protein Kinase C - pharmacology</subject><subject>Protein Kinase C beta</subject><subject>Protein Kinase C-epsilon - genetics</subject><subject>Protein Kinase C-epsilon - metabolism</subject><subject>Protein Kinase C-epsilon - pharmacology</subject><subject>Protein Structure, Tertiary - physiology</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Serine - genetics</subject><subject>Serine - metabolism</subject><subject>Thionucleotides - pharmacology</subject><subject>Threonine - genetics</subject><subject>Xenopus laevis</subject><subject>Xenopus Proteins - drug effects</subject><subject>Xenopus Proteins - genetics</subject><subject>Xenopus Proteins - metabolism</subject><issn>0306-4522</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j7FOwzAURT2AaCn8ArKYYEh4z3YcZ6wiCpEqMVCxocpxXsAldaI4HcrXUwm4yxmOdKTL2C1CioD6YZcGOox9dJ6Co1QAmBRFCio_Y3OQoBOVCTFjlzHu4LRMyQs2wwJ1rjTO2furnyiJAznfesdH-jh0dvJ94H3Ly-Xd271IBXefNgTqIq-PfBj7iXzgXz7YSLzkPvbfxz2dJE22qrgNDach-q4PV-y8tV2k6z8u2Gb1uCmfk_XLU1Uu18mQKUwyk6MpQLhaS1QAtlVKt8ZALhsSBeSgMytIoROQF9agQm0JjGw0Sm1quWA3v9nhUO-p2Q6j39vxuP2_KX8A6ExUtg</recordid><startdate>20090317</startdate><enddate>20090317</enddate><creator>Rajagopal, S</creator><creator>Fang, H</creator><creator>Oronce, C I A</creator><creator>Jhaveri, S</creator><creator>Taneja, S</creator><creator>Dehlin, E M</creator><creator>Snyder, S L</creator><creator>Sando, J J</creator><creator>Kamatchi, G L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20090317</creationdate><title>Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon</title><author>Rajagopal, S ; Fang, H ; Oronce, C I A ; Jhaveri, S ; Taneja, S ; Dehlin, E M ; Snyder, S L ; Sando, J J ; Kamatchi, G L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p541-58718902cb631400af446f88073de2907065a2e41c2079a81416ae083d61368b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Aspartic Acid - genetics</topic><topic>Calcium Channels, N-Type - drug effects</topic><topic>Calcium Channels, N-Type - genetics</topic><topic>Calcium Channels, N-Type - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Activation - genetics</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene Expression Regulation - physiology</topic><topic>Guanosine Diphosphate - analogs &amp; derivatives</topic><topic>Guanosine Diphosphate - pharmacology</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - genetics</topic><topic>Microinjections - methods</topic><topic>Mutation - genetics</topic><topic>Oocytes</topic><topic>Patch-Clamp Techniques</topic><topic>Phorbol Esters - pharmacology</topic><topic>Phosphorylation - genetics</topic><topic>Protein Kinase C - genetics</topic><topic>Protein Kinase C - metabolism</topic><topic>Protein Kinase C - pharmacology</topic><topic>Protein Kinase C beta</topic><topic>Protein Kinase C-epsilon - genetics</topic><topic>Protein Kinase C-epsilon - metabolism</topic><topic>Protein Kinase C-epsilon - pharmacology</topic><topic>Protein Structure, Tertiary - physiology</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Serine - genetics</topic><topic>Serine - metabolism</topic><topic>Thionucleotides - pharmacology</topic><topic>Threonine - genetics</topic><topic>Xenopus laevis</topic><topic>Xenopus Proteins - drug effects</topic><topic>Xenopus Proteins - genetics</topic><topic>Xenopus Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rajagopal, S</creatorcontrib><creatorcontrib>Fang, H</creatorcontrib><creatorcontrib>Oronce, C I A</creatorcontrib><creatorcontrib>Jhaveri, S</creatorcontrib><creatorcontrib>Taneja, S</creatorcontrib><creatorcontrib>Dehlin, E M</creatorcontrib><creatorcontrib>Snyder, S L</creatorcontrib><creatorcontrib>Sando, J J</creatorcontrib><creatorcontrib>Kamatchi, G L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rajagopal, S</au><au>Fang, H</au><au>Oronce, C I A</au><au>Jhaveri, S</au><au>Taneja, S</au><au>Dehlin, E M</au><au>Snyder, S L</au><au>Sando, J J</au><au>Kamatchi, G L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2009-03-17</date><risdate>2009</risdate><volume>159</volume><issue>2</issue><spage>618</spage><pages>618-</pages><issn>0306-4522</issn><abstract>Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocytes can be blocked by inhibitors of PKC betaII or PKC epsilon isozymes, as shown previously for Ca(v)2.3 currents, and that microinjection of PKC betaII or PKC epsilon isozymes in the oocytes expressing the WT Ca(v)2.2 channels increases the basal barium current (I(Ba)). The I-V plot shows a large increase in current amplitude with PKC betaII and PKC epsilon isozymes with only a small shift in the peak I(Ba) in the hyperpolarizing direction. The potentiation of Ca(v)2.2 currents by microinjection of PKC betaII and PKC epsilon isozymes was not altered by the inhibition of G proteins with GDPbetaS. The combination of isozyme specific inhibitors with previously generated Ser/Thr to Ala mutants of alpha(1) 2.2 subunit revealed that PKC betaII or PKC epsilon isozymes (but not PKC alpha or delta) can provide full enhancement through the stimulatory site (Thr-422) in the I-II linker but that PKC epsilon is better at decreasing channel activity through the inhibitory site Ser-425. The enhancing effect of PKC betaII or epsilon at Thr-422 is dominant over the inhibitory effect at Ser-425. Injected PKC betaII also enhances Ca(v)2.2 current when any of the potential stimulatory sites (Ser-1757, Ser-2108 and Ser-2132) are available in the C-terminus. PKC epsilon provides lesser enhancement with C-terminal sites and only with Ser-2108 and Ser-2132. Sites Ser-1757 and Ser-2132, but not Ser-2108, are dominant over the inhibitory site Ser-425. Collectively, these results reveal a hierarchy of regulatory sites in Ca(v)2.2 channels. Site-specific regulation by different PKC isozymes may allow graded levels of channel activation and susceptibility or resistance to subsequent stimulatory events.</abstract><cop>United States</cop><pmid>19167461</pmid><doi>10.1016/j.neuroscience.2008.12.047</doi></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2009-03, Vol.159 (2), p.618
issn 0306-4522
language eng
recordid cdi_pubmed_primary_19167461
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Aspartic Acid - genetics
Calcium Channels, N-Type - drug effects
Calcium Channels, N-Type - genetics
Calcium Channels, N-Type - metabolism
Dose-Response Relationship, Drug
Enzyme Activation - drug effects
Enzyme Activation - genetics
Enzyme Inhibitors - pharmacology
Female
Gene Expression Regulation - drug effects
Gene Expression Regulation - physiology
Guanosine Diphosphate - analogs & derivatives
Guanosine Diphosphate - pharmacology
Membrane Potentials - drug effects
Membrane Potentials - genetics
Microinjections - methods
Mutation - genetics
Oocytes
Patch-Clamp Techniques
Phorbol Esters - pharmacology
Phosphorylation - genetics
Protein Kinase C - genetics
Protein Kinase C - metabolism
Protein Kinase C - pharmacology
Protein Kinase C beta
Protein Kinase C-epsilon - genetics
Protein Kinase C-epsilon - metabolism
Protein Kinase C-epsilon - pharmacology
Protein Structure, Tertiary - physiology
RNA, Small Interfering - pharmacology
Serine - genetics
Serine - metabolism
Thionucleotides - pharmacology
Threonine - genetics
Xenopus laevis
Xenopus Proteins - drug effects
Xenopus Proteins - genetics
Xenopus Proteins - metabolism
title Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A02%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Site-specific%20regulation%20of%20CA(V)2.2%20channels%20by%20protein%20kinase%20C%20isozymes%20betaII%20and%20epsilon&rft.jtitle=Neuroscience&rft.au=Rajagopal,%20S&rft.date=2009-03-17&rft.volume=159&rft.issue=2&rft.spage=618&rft.pages=618-&rft.issn=0306-4522&rft_id=info:doi/10.1016/j.neuroscience.2008.12.047&rft_dat=%3Cpubmed%3E19167461%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19167461&rfr_iscdi=true